In July, Bristol-Myers Squibb announced the recall of some of their 5 mg single-use Coumadin injections. Six lots are affected in the recall: 00201125, 00201126, 00201127, 00201128, 00201129, and 00201130. The voluntary nationwide recall is a result of visible particulate matter found in some unreleased samples. These lots were distributed in six-count cartons to pharmacies from November 2011 through January 2014. The expiration dates stagger from September 2014 until September 2015. [click to continue…]
{ 0 comments }